Agmatine Crosses the Blood-Brain Barrier

Annals of the New York Academy of Sciences

Volumn 1009, Issue , 2003, Pages 64-74

  Piletz, J E ^a,b   May, P J ^a   Wang, G ^a,c   Zhu, H ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b JACKSON STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Agmatine; Arginine; Blood brain barrier; Cerebrospinal fluid; Monkey

Indexed keywords

AGMATINE; ARGININE;

BLOOD BRAIN BARRIER; BLOOD SAMPLING; BRAIN PERFUSION; CEREBROSPINAL FLUID; CISTERNA MAGNA; CONFERENCE PAPER; DRUG ABSORPTION; DRUG BRAIN LEVEL; EXPERIMENTAL MODEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INHALATION ANESTHESIA; NONHUMAN; RHESUS MONKEY; SPECIES COMPARISON;

ANIMALIA; MACACA MULATTA; TRIXIS;

EID: 1342305412     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1304.007     Document Type: Conference Paper

References (21)

1. LI, G., S. REGUNATHAN, C.J. BARROW, et al. 1994. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263: 966-969.
2. REGUNATHAN, S. & D.J. REIS. 2000. Characterization of arginine decarboxylase in rat brain and liver: distinction from ornithine decarboxylase. J. Neurochem. 74: 2201-2208.
3. REIS, D.J. & S. REGUNATHAN. 2000. Is agmatine a novel neurotransmitter in brain? Trends Pharmacol. Sci. 21: 187-193.
4. DEMADY, D.R., S. JIANMONGKOL, J.L. VULETICH, et al. 2001. Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme. Mol. Pharmacol. 59: 24-29.
5. REIS, D.J., X.C. YANG & T.A. MILNER. 1998. Agmatine containing axon terminals in rat hippocampus form synapses on pyramidal cells. Neurosci. Lett. 250: 185-188.
6. REIS, D.J. & S. REGUNATHAN. 1999. Agmatine: an endogenous ligand at imidazoline receptors is a novel neurotransmitter. Ann. N. Y. Acad. Sci. 881: 65-80.
7. OLMOS, G., N. DEGREGORIO-ROCASOLANO, M. PAZ REGALADO, et al. 1999. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br. J. Pharmacol. 127: 1317-1326.
8. FENG, Y., J.E. PILETZ & M.H. LEBLANC. 2002. Agmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res 52: 606-611.
9. ZHU, M.-Y., J. PILETZ, A. HALARJS, et al. 2002. Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC 12 cell. Cell. Mol. Neurobiol. 23: 865-872.
10. GILAD, G.M., K. SALAME, J.M. RABEY, et al. 1996. Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci. 58: 41-46.
11. FAIRBANKS, C.A., K.L. SCHREIBER, K.L. BREWER, et al. 2000. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 97: 10584-10589.
12. KOLESNIKOV, Y., S. JAIN & G.W. PASTERNAK. 1996. Modulation of opioid analgesia by agmatine. Eur. J. Pharmacol. 296: 17-22.
13. UZBAY, I.T., O. YESILYURT, T. CELIK, et al. 2000. Effects of agmatine on ethanol withdrawal syndrome in rats. Behav. Brain Res. 107: 153-159.
14. STEWART, L.S. & B.E. MCKAY. 2000. Acquisition deficit and time-dependent retrograde amnesia for contextual fear conditioning in agmatine-treated rats. Behav. Pharmacol. 11: 93-97.
15. ZOMKOWSKI, A.D., L. HAMMES, J. LIN, et al. 2002. Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport 13: 387-391.
16. ARICIOGLU-KARTAL, F. & I.T. UZBAY. 1997. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats. Life Sci. 61: 1775-1781.
17. BRADLEY, K.J. & P.M. HEADLEY. 1997. Effect of agmatine on spinal nociceptive reflexes: lack of interaction with alpha2-adrenoceptor or mu-opioid receptor mechanisms. Eur. J. Pharmacol. 331: 133-138.
18. TANGPHAO, O., M. GROSSMANN, S. CHALON, et al. 1999. Pharmacokinetics of intravenous and oral L-arginine in normal volunteers. Br. J. Clin. Pharmacol. 47: 261-266.
19. PENNER, S.B. & D.D. SMYTH. 1996. Natriuresis following central and peripheral administration of agmatine in the rat. Pharmacology 53: 160-169.
20. FENG, Y., A.E. HALARIS & J.E. PILETZ. 1997. Determination of agmatine in brain and plasma using high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B: Biomedical Applications 691(2): 277-282.
21. HALARIS, A., H. ZHU, Y. FENG, et al. 1999. Plasma agmatine and platelet imidazoline receptors in depression. Ann. N. Y. Acad. Sci. 881: 445-451.